Not Signed In -
Alzheimer's Disease |
AD; Alzheimer disease; Alzheimer//'s disease; Alzheimer///'s disease; DAT - Dementia Alzheimer's type; familial Alzheimer disease (FAD); Presenile and senile dementia; Primary Senile Degenerative Dementia; SDAT |
"Alzheimer" redirects here. For other uses, see Alzheimer (disambiguation). Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive deterioration together with declining activities of daily living and neuropsychiatric symptoms or behavioral changes. It is the most common cause of dementia. The most striking early symptom is memory loss (amnesia), which usually manifests as minor forgetfulness that becomes steadily more pronounced with illness progre ...
Wikipedia - [full article]
Alzheimer's Disease Clinical Trials
- ADNI: Alzheimer's Disease Neuroimaging Initiative
ClinicalTrials.gov Identifier: NCT00106899 - Active, not recruiting
Alzheimer's Disease
- Effects of an Anti-Inflammatory Drug in Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00013650 - Active, not recruiting
Alzheimer's Disease
- Study of an Investigational Drug for the treatment of Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00074529 - Active, not recruiting
Alzheimer's Disease
- Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00454870 - Active, not recruiting
Alzheimer's Disease
- Double-Blind, Placebo-Controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00377715 - Active, not recruiting
Alzheimer's Disease
- Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00471211 - Active, not recruiting
Alzheimer's Disease
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00287742 - Active, not recruiting
Alzheimer's Disease; Dementia
- Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00314912 - Active, not recruiting
Alzheimer's Disease
- Safety Study of Passive Immunization for Patients With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00174525 - Active, not recruiting
Alzheimer's Disease
- Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00329082 - Active, not recruiting
Alzheimer's Disease
- Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00299988 - Active, not recruiting
Alzheimer's Disease
- A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00322153 - Active, not recruiting
Alzheimer's Disease
- Prevention of cognitive decline in Alzheimer's disease by ingested interferon alpha
ClinicalTrials.gov Identifier: NCT00031018 - Recruiting
Memory Disorders; Alzheimer's Disease
- CERE-110 in Subjects with Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00087789 - Recruiting
Alzheimer's Disease
- A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00164749 - Active, not recruiting
Alzheimer's Disease
- MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00362024 - Active, not recruiting
Alzheimer's Disease
- Memory Aid for Informed Consent in Alzheimer's Research
ClinicalTrials.gov Identifier: NCT00105612 - Active, not recruiting
Alzheimer's Disease; Aging
- fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00478491 - Enrolling by invitation
Magnetic Resonance Imaging; Alzheimer's Disease; Dementia; Adult Children; Risk
- SB-742457 And Donepezil In Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00348192 - Active, not recruiting
Alzheimer's Disease
- DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00440050 - Active, not recruiting
Alzheimer's Disease
- Alzheimer's Caregiver Communication Study
ClinicalTrials.gov Identifier: NCT00182988 - Active, not recruiting
Alzheimer's Disease
- Depression in Alzheimer's Disease (DIADS-2)
ClinicalTrials.gov Identifier: NCT00086138 - Recruiting
Alzheimer's Disease; Depression
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00348140 - Recruiting
Alzheimer's Disease
- Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept
ClinicalTrials.gov Identifier: NCT00384423 - Recruiting
Alzheimer's Disease
- A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00455000 - Recruiting
Alzheimer's Disease
- A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776A) in Patients With Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00459550 - Recruiting
Alzheimer's Disease
- Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)
ClinicalTrials.gov Identifier: NCT00523666 - Recruiting
Alzheimer's Disease
- AIDMA: A Psycho-Educational Program Designed to Support and Train Carers of Alzheimer's Disease (AD) Patients
ClinicalTrials.gov Identifier: NCT00190372 - Recruiting
Alzheimer's Disease
- Safety and Tolerability of Long-Term Treatment by Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00531609 - Recruiting
Alzheimer's Disease
- Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00359944 - Recruiting
Alzheimer's Disease
- Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients
ClinicalTrials.gov Identifier: NCT00369603 - Recruiting
Alzheimer's Disease
- Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00423085 - Recruiting
Alzheimer's Disease
- Rosiglitazone (Extended Release Tablets) Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00428090 - Recruiting
Alzheimer's Disease
- Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00495417 - Recruiting
Alzheimer's Disease
- Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00555204 - Recruiting
Alzheimer's Disease
- Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00381238 - Recruiting
Alzheimer's Disease
- Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)
ClinicalTrials.gov Identifier: NCT00411580 - Recruiting
Alzheimer's Disease
- MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems
ClinicalTrials.gov Identifier: NCT00413621 - Recruiting
Alzheimer's Disease
- Clinical Effectiveness of 10 cm2 Rivastigmine Patch in Patients With Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00561392 - Recruiting
Alzheimer's Disease
- A Multi-Center Study for the Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00381381 - Recruiting
Alzheimer's Disease
- Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00549601 - Recruiting
Alzheimer's Disease
- MRS and DTI of White Matter in Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00172900 - Recruiting
Alzheimer's Disease; Vascular Dementia
- The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients
ClinicalTrials.gov Identifier: NCT00255086 - Recruiting
Alzheimer's Disease
- Brain Imaging Study of Rosiglitazone Efficacy and Safety in Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00265148 - Recruiting
Alzheimer's Disease
- European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients
ClinicalTrials.gov Identifier: NCT00357357 - Recruiting
Alzheimer's Disease
- Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00423228 - Recruiting
Alzheimer's Disease
- Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid
ClinicalTrials.gov Identifier: NCT00439166 - Recruiting
Alzheimer's Disease
- Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00476008 - Recruiting
Alzheimer's Disease
- Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00408525 - Recruiting
Alzheimer's Disease
- Home Safety Clinical Trial for Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00459355 - Recruiting
Alzheimer's Disease; Dementia
- Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00469456 - Recruiting
Alzheimer's Disease
- Biomarkers and Early Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00094952 - Recruiting
Alzheimer's Disease
- Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00574132 - Recruiting
Alzheimer's Disease
- Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00575055 - Recruiting
Alzheimer's Disease
- Ginkgo Biloba Prevention Trial in Older Individuals
ClinicalTrials.gov Identifier: NCT00010803 - Active, not recruiting
Dementia; Alzheimer's Disease
- MK0249 for the Symptomatic Treatment of Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00420420 - Recruiting
Alzheimer's Disease
- Neural Correlates in Mild Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00477659 - Recruiting
Alzheimer's Disease
- Memory and Insulin in Early Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00581867 - Recruiting
Alzheimer's Disease
- Effect of Activity on Sleep of Cognitively-Impaired Veterans
ClinicalTrials.gov Identifier: NCT00013182 - Active, not recruiting
Alzheimer's Disease; Sleep Disorders
- MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology
ClinicalTrials.gov Identifier: NCT00239759 - Recruiting
Alzheimer's Disease
- Efficacy of Early Stage Alzheimer's Support Groups
ClinicalTrials.gov Identifier: NCT00391794 - Recruiting
Memory Loss; Alzheimer's Disease; Dementia
- Online Caregiver Psychoeducation and Support for Alzheimer's
ClinicalTrials.gov Identifier: NCT00416078 - Recruiting
Alzheimer's Disease
- Open-Label Extension Study of 23mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00566501 - Not yet recruiting
Alzheimer's Disease
- Raloxifene for Women With Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00368459 - Recruiting
Alzheimer's Disease
- A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00443417 - Not yet recruiting
Alzheimer's Disease
- Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00104442 - Completed
Alzheimer's Disease
- Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00478205 - Recruiting
Alzheimer's Disease
- Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II
ClinicalTrials.gov Identifier: NCT00089882 - Active, not recruiting
Alzheimer Disease
- Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
ClinicalTrials.gov Identifier: NCT00053599 - Active, not recruiting
Alzheimer Disease
- Effects on sleep and attention of two currently marketed drugs for Alzheimer's disease
ClinicalTrials.gov Identifier: NCT00035204 - Completed
Alzheimer's Disease
- Computer-Based Training for Mild Alzheimer’s Disease
ClinicalTrials.gov Identifier: NCT00319891 - Active, not recruiting
Alzheimer's Disease
- Memantine for Agitation and Aggression in Severe Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00401167 - Not yet recruiting
Alzheimer's Disease
- Safety Study of Nicotinamide to Treat Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00580931 - Not yet recruiting
Alzheimer's Disease
- Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer’s Disease
ClinicalTrials.gov Identifier: NCT00257673 - Active, not recruiting
Alzheimer's Disease
- Brain Study of Patients with Frontal Lobe Dementia and Parkinsonian Disorders
ClinicalTrials.gov Identifier: NCT00001178 - Recruiting
Alzheimer's Disease; Dementia; Down's Syndrome
- Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study
ClinicalTrials.gov Identifier: NCT00216593 - Active, not recruiting
Dementia; Alzheimer Disease
- Efficacy and Safety of LY451395 in Patients with Probable Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00051909 - Completed
Alzheimer's Disease
- Alzheimer's Disease: Therapeutic Potential of Estrogen
ClinicalTrials.gov Identifier: NCT00066157 - Active, not recruiting
Alzheimer Disease
- Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer’s Disease)
ClinicalTrials.gov Identifier: NCT00334906 - Active, not recruiting
Alzheimer's Disease
- CATIE-Alzheimer's Disease Trial
ClinicalTrials.gov Identifier: NCT00015548 - Completed
Alzheimer's Disease
- An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients with Moderate to Severe Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00097916 - Completed
Alzheimer's Disease
- VITAL - VITamins to slow ALzheimer's disease (Homocysteine Study)
ClinicalTrials.gov Identifier: NCT00056225 - Completed
Alzheimer's Disease
- Brain Imaging in Elderly People and Individuals with Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00001917 - Completed
Alzheimer's Disease; Healthy
- Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00096473 - Completed
Alzheimer's Disease; Dementia
- An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-Month Period
ClinicalTrials.gov Identifier: NCT00299676 - Active, not recruiting
Dementia; Alzheimer Disease; Galantamine
- The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
ClinicalTrials.gov Identifier: NCT00571064 - Not yet recruiting
Mild to Severe Alzheimer's Disease
- Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer’s Disease
ClinicalTrials.gov Identifier: NCT00480701 - Recruiting
Alzheimer's Disease; Parkinson Disease
- the Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's Disease.
ClinicalTrials.gov Identifier: NCT00283725 - Active, not recruiting
Alzheimer Disease; Dementia
- PET Changes in Alzheimer's Disease (AD)
ClinicalTrials.gov Identifier: NCT00094913 - Active, not recruiting
Alzheimer Disease
- The Depression in Alzheimer's Disease Study (DIADS)
ClinicalTrials.gov Identifier: NCT00009191 - Active, not recruiting
Alzheimer Disease; Depression
- Curcumin in Patients with Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00099710 - Completed
Alzheimer's Disease
- The Safety and Efficacy of Neramexane in Patients with Moderate to Severe Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00090116 - Completed
Alzheimer's Disease
- Evaluation of Alzhemed™ in Patients with Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00088673 - Active, not recruiting
Alzheimer Disease
- SGS742 in Patients with Mild to Moderate Alzheimer's Disease (AD)
ClinicalTrials.gov Identifier: NCT00093951 - Completed
Alzheimer's Disease
- TRx0014 in Patients With Mild or Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00515333 - Active, not recruiting
Dementia, Alzheimer Type
- Bathing persons with Alzheimer's disease aT Home (The BATH Study)
ClinicalTrials.gov Identifier: NCT00062569 - Recruiting
Alzheimer Disease
- REVEAL III: Risk Evaluation and Education for Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00462917 - Recruiting
Alzheimer Disease
- Development of NIC5-15 in the Treatment of Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00470418 - Recruiting
Alzheimer Disease; Dementia
- Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00551161 - Recruiting
Alzheimer Disease
- Couples Coping With Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00438724 - Recruiting
Aging; Alzheimer Disease; Dementia
Resources
- (National Women's Health Information Center, OWH, HHS)
- ''''The Free-Radical Theory of Aging: Part I - How it all began'''' (HealthWorld)
email this page
print this page
bookmark this page
feedback on this page
